ICL Group (NYSE: ICL) EVP discloses large stock option grants
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
ICL Group Ltd. executive Uri Perelman filed an initial ownership report showing existing stock option holdings in the company. He holds options over 1,139,990 Ordinary Shares with a $6.03 exercise price expiring on April 4, 2029, and options over 739,400 Ordinary Shares with a $6.93 exercise price expiring on April 1, 2030. The first grant vests in three equal annual installments from the April 4, 2024 grant date, while the second vests in three installments of 50%, 35% and 15% from the April 1, 2025 grant date. The options are held by a trustee in Perelman’s name, and the filing does not report any new purchases or sales, only these derivative holdings.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Perelman Uri
Role
EVP, ICL Chief Corp. Biz Dev
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 1,139,990 shares (Direct)
Footnotes (1)
- The stock options vest in three equal annual installments from the April 4, 2024, grant date. The stock options vast in three annual installments (50%, 35% and 15%) from April 1, 2025, grant date. Represents an exercise price of NIS 18.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026. The options are held by a Trustee in the name of the Reporting Person. Represents an exercise price of NIS 21.81, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.
Key Figures
First option underlying shares: 1,139,990 shares
First option exercise price: $6.03 per share
Second option underlying shares: 739,400 shares
+3 more
6 metrics
First option underlying shares
1,139,990 shares
Ordinary Shares underlying options at $6.03 exercise price, expiring April 4, 2029
First option exercise price
$6.03 per share
Exercise price for options over 1,139,990 Ordinary Shares
Second option underlying shares
739,400 shares
Ordinary Shares underlying options at $6.93 exercise price, expiring April 1, 2030
Second option exercise price
$6.93 per share
Exercise price for options over 739,400 Ordinary Shares
First grant vesting start
April 4, 2024
Grant date; options vest in three equal annual installments
Second grant vesting start
April 1, 2025
Grant date; options vest 50%, 35%, 15% over three years
Key Terms
Stock Options (Right to Buy), Ordinary Shares, exercise price, vest, +1 more
5 terms
Stock Options (Right to Buy) financial
"security_title: Stock Options (Right to Buy)"
exercise price financial
"Represents an exercise price of NIS 18.99, converted to U.S. dollars"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"The stock options vest in three equal annual installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Trustee financial
"The options are held by a Trustee in the name of the Reporting Person."
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.
FAQ
What does the Form 3 filing by ICL (ICL) executive Uri Perelman show?
The Form 3 shows existing stock option holdings by EVP Uri Perelman in ICL Group Ltd. It lists two option grants over more than 1.8 million Ordinary Shares, including exercise prices, expirations, and vesting schedules, without reporting any new share purchases or sales.
What are the exercise prices and expirations of Uri Perelman’s ICL stock options?
One grant has a $6.03 exercise price and expires on April 4, 2029. The other has a $6.93 exercise price and expires on April 1, 2030. These figures indicate the prices at which he can purchase Ordinary Shares before each option’s expiration.
How do Uri Perelman’s ICL (ICL) stock options vest according to the filing?
The first option grant vests in three equal annual installments starting from the April 4, 2024 grant date. The second vests in three annual installments of 50%, 35% and 15% beginning from the April 1, 2025 grant date, shaping when options become exercisable.
Are Uri Perelman’s ICL stock options held directly or through another entity?
The filing states the options are held by a Trustee in the name of the reporting person, Uri Perelman. This means a trustee entity legally holds the options on his behalf, but the Form 3 attributes the beneficial ownership to him.
Does Uri Perelman’s Form 3 for ICL (ICL) indicate recent buying or selling activity?
No, the Form 3 does not report new transactions. It classifies the records as holdings, with unknown transaction codes and no buy or sell entries. The disclosure simply establishes his existing derivative positions as a company officer.